Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.